Cut Your Pressure Too: The Los Angeles Barbershop Blood Pressure Study

July 6, 2018 updated by: Ron Victor, Cedars-Sinai Medical Center

Barber-Pharmacist Coordination to Improve Blood Pressure Management in Black Men

African-American men suffer more than most other groups from hypertension (HTN) but often have less access and less contact with doctors. Previous work by the study's Principal Investigator in Dallas, Texas, and Altadena, California, showed that barbershops are an excellent place to identify black men with high blood pressure and to enlist the aid of their barbers as healthcare extenders.

The purpose of this study in Metro Los Angeles (LA) is to compare two types of barber-based patient-centered blood pressure programs to see which type is more effective in improving the customers' high blood pressure. One type emphasizes blood pressure medication and the other type emphasizes lifestyle modification for high blood pressure.

Study Overview

Detailed Description

Uncontrolled hypertension (HTN) is one of the most important causes of premature disability and death among non-Hispanic black men. Indeed, black men have the highest HTN death rate of any U.S. race, ethnic, or gender group, contributing to a lower life expectancy. The age-adjusted HTN-related death rate is 3.3-times higher among black men than white men. To address this major health disparity, the investigators designed a novel community-partnered team approach to improve HTN management among black men and prevent needless strokes, heart attacks, kidney failure, and heart failure.

HTN requires physician (or middle-level provider) interaction to optimize blood pressure (BP) medication; black men have less interaction than black women; and thus far lower rates of HTN treatment (73% vs. 86%) and control (36% vs. 50%). Black-owned barbershops are a uniquely personal setting to discuss health with influential male peers. Barbershop health outreach is well-established, but untested as a vehicle for improving HTN control. Scientific evaluation is crucial to best allocate finite healthcare dollars and avoid promoting a "community health industry" that benefits only the promoters.

Under-treatment of HTN is common in primary care due to competing demands on physicians' time. The best way to improve HTN control is with team-based approaches enlisting pharmacists. They are more accessible than physicians, more knowledgeable about medication, and receive training on patient education. The investigators' new conceptual model links the barber-based intervention to team-based care delivery.

The purpose of this research study is to compare this new conceptual model to another barber-based patient-centered blood pressure program to see which is more effective in improving high blood pressure among Black patrons of African American owned barbershops in LA. Patrons randomized to Group 1 (the new conceptual model) will provide blood pressure readings for patrons aged 35 to 79 years of age and refer those with HTN to a Clinical Pharmacist to work with their doctors in optimizing blood pressure medication.

Patrons of Group 1 shops will also be exposed to role model posters are not intended as recruitment materials, but rather are educational tools that intend to highlight positive experiences of participation. The text of the role model stories will in no way provide statements of the effectiveness of the intervention being evaluated by the present research study. Rather, they are the main health messaging tools needed to promote completion of the program in order to achieve the experiences described. Essentially the document will be used as an intervention tool for peer-based health messaging - stories from real customers in the barbershop modeling target behaviors leading that promote continued participation in the protocol by peers with the hopes of achieving to the detection, treatment, and control of high blood pressure. Each role model story will encourage one of two desired health behaviors of potential subjects with elevated BP: 1) ask the barber to check patients' BP with each haircut, 2) schedule a follow-up visit with the study pharmacist to get patient's blood pressure under control. Large posters in the barbershop will show the model customer, his barber, and the study pharmacist who facilitated the desired behavior change. The model's (participants) own words will be used on the poster.

Group 2 barbershop patrons will be exposed to up-to-date information on high blood pressure and on lifestyle topics for blood pressure and heart health including weight management, healthy cooking, cholesterol lowering, and exercise.

A pre-specified cross-sectional sub study utilized the trial's initial screening population to test for an association between self-reported nocturia (>2 nightly/voids) and elevated daytime (in-barbershop) blood pressure.

Study Type

Interventional

Enrollment (Actual)

320

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Los Angeles, California, United States, 90048
        • Cedars-Sinai Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 79 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • 35 to 79 years of age
  • Non-Hispanic Black men
  • Long-term/frequent barbershop patronage (barbershop patrons having at least one haircut every 6 weeks in the same barbershop for the past 6 months).
  • Systolic BP >140 at 2 screenings on 2 separate days
  • Complete set of Baseline Data

Exclusion Criteria:

  • Women
  • Children
  • <35 years of age
  • Non-black
  • Hispanic ethnicity
  • New/infrequent patronage (<8 haircuts at same barbershop in last 12 months)
  • Systolic BP <140 at either screening
  • Currently receiving cancer chemotherapy
  • On Dialysis
  • Incomplete baseline data
  • Serious Plan to Move in the next 1.5 years
  • Plans to be out of the area for > 1 month in the next 1.5 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: BP measurement & pharmacy
BP measurements performed by barber, role model poster exposure in barbershop, and BP medication management visits with study pharmacist
Blood pressure monitoring by barber, blood pressure medication management by pharmacist, role model posters encouraging program participation
Other: BP educational materials
Exposure to hypertension educational materials in barbershop
Exposure to hypertension educational materials

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Primary Blood Pressure Outcome - change in systolic blood pressure
Time Frame: 6 months
The pre-specified primary outcome was the change in systolic blood pressure from baseline to 6 months follow-up.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Secondary Blood Pressure Outcome - change in diastolic blood pressure
Time Frame: 6 months
The change in diastolic blood pressure from baseline to 6 month follow-up
6 months
The percentage of participants achieving blood pressure goal
Time Frame: 6 months
The percentage of participants who achieved blood pressure goal after 6 months follow-up (140/90,135/85, 130/80)
6 months
The change in number/type of drug classes prescribed
Time Frame: 6 months
The change in number/class of prescription drugs prescribed from baseline to 6 month follow-up
6 months
Adverse Drug Reactions
Time Frame: 6 months
The number and type of adverse drug reactions reported from baseline to 6 month follow-up
6 months
Self-Rated Health
Time Frame: 6 months
The change in self-rated health score from baseline to 6 month follow-up
6 months
Self-Rated Patient Engagement
Time Frame: 6 months
The change in PACIC patient engagement score from baseline to 6 month follow-up
6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Extension Study Primary Blood Pressure Outcome - change in systolic blood pressure
Time Frame: 12 months
The primary outcome of the extension study is the change in systolic blood pressure from baseline to 12 months follow-up.
12 months
Extension Study Secondary Blood Pressure Outcome - change in diastolic blood pressure
Time Frame: 12 months
The change in diastolic blood pressure from baseline to 12 month follow-up
12 months
Extension Study Secondary Outcome - the percentage of participants achieving blood pressure goal
Time Frame: 12 months
The percentage of participants who achieved blood pressure goal after 12 months follow-up (140/90,135/85, 130/80)
12 months
Extension Study Secondary Outcome - the change in number/type of drug classes prescribed
Time Frame: 12 months
The change in number/class of prescription drugs prescribed from baseline to 12 month follow-up
12 months
Extension Study Secondary Outcome - adverse drug reactions
Time Frame: 12 months
The number and type of adverse drug reactions reported from baseline to 12 month follow-up
12 months
Extension Study Secondary Outcome - self-rated health
Time Frame: 12 months
The change in self-rated health from baseline to 12 month follow-up
12 months
Extension Study Secondary Outcome - self-rated patient engagement
Time Frame: 12 months
The change in PACIC patient engagement score from baseline to 12 month follow-up
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 17, 2015

Primary Completion (Actual)

June 30, 2017

Study Completion (Actual)

January 9, 2018

Study Registration Dates

First Submitted

December 17, 2014

First Submitted That Met QC Criteria

December 19, 2014

First Posted (Estimate)

December 22, 2014

Study Record Updates

Last Update Posted (Actual)

July 10, 2018

Last Update Submitted That Met QC Criteria

July 6, 2018

Last Verified

July 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Pro00035347
  • 5R01HL117983-02 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe